INS and diabetic neuropathy: Due to its role in the clearance of insulin, the identification of drugs that selectively modulate IDE activity toward insulin is proposed by many authors as a promising therapeutic strategy for the cure of TDM2 and of its complications, such as diabetic neuropathy and retinopathy.